Live
- BJP won’t succeed in toppling Congress govt: K’taka Home Minister
- Turkey neutralises five Kurdish militants in Syria
- BJP questions Kejriwal on 21,000 deaths in Delhi due to contaminated water
- CM Revanth Reddy Inspects Progress of Telangana Mother Statue Installation
- ‘It’s Congress habit to spread lies’, says Vinod Tawde after sending legal notice to Kharge, Rahul
- Hungarian PM invites Netanyahu for visit, calls ICC warrants 'brazen and cynical'
- Lt Gen Suchindra Kumar reviews indigenously developed ‘Asmi’ machine pistols
- Who is AP's Next CM: Chandrababu Naidu Makes Key Comments in Assembly
- Engineering goods exports shoot past $10 bn in Oct, US & EU top markets
- India’s foreign exchange reserves stand at $657.89 billion
Delhi HC dismisses PIL seeking directions to medical professionals to reveal side effects of medicines
The Delhi High Court has dismissed a public interest litigation (PIL) seeking a direction to all medical professionals to provide an additional slip detailing possible risks and side effects associated with prescribed medicines.
New Delhi: The Delhi High Court has dismissed a public interest litigation (PIL) seeking a direction to all medical professionals to provide an additional slip detailing possible risks and side effects associated with prescribed medicines.
A Bench, headed by Acting Chief Justice Manmohan, said that since the legislature, in its wisdom, has elected to impose this duty on the manufacturer and the pharmacist, it would "amount to judicial legislation" if a direction is issued as prayed for in the PIL.
"It is admitted that there is no (legal) vacuum, the directions prayed for cannot be issued. Accordingly, the present PIL along with applications is dismissed," the bench, also comprising Justice Manmeet Pritam Singh Arora, ordered.
The PIL said that the patient has a right to make an informed choice and therefore, it should be mandatory for the doctor prescribing the drug to explain the side effects and possible risks attached to the prescribed drugs.
It added that upon being made aware of the side effects of the drug being prescribed by the doctor, the patient would be able to make an informed choice, whether to consume it or not.
Referring to the existing regime, where the obligation to communicate the potential risks and side effects exists on the manufacturer and the pharmacists, the plea said that it is the medical practitioner prescribing the drug, who should be made responsible for handing out the information about the potential risk to the patient in the regional language.
In its response, the Union government stated that the Drugs and Cosmetics Act, 1945 and the Pharmacy Practice Regulations, 2015 already ensure that the risk is duly communicated to the patient, adding that the direction sought would hinder rather than facilitate medical advice to the patients.
--IANS
pds/vd
